Evidence map›Paper›PMID 31657895›Full record

ReviewACS chemical neuroscience2020

DARK Classics in Chemical Neuroscience: NBOMes.

Christian B M Poulie, Anders A Jensen, Adam L Halberstadt, Jesper L Kristensen

Open access · greenAbstract readReview
In one paragraph

Review in ACS chemical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Psychedelic enhancement of flexible learning weeks after a single dose.bioRxiv : the preprint server for biology · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Molecular and Medical Aspects of Psychedelics.International journal of molecular sciences · 2023
    Review
  9. Article
  10. ACS pharmacology & translational science · 2023
    Article
  11. The PsychedelicACS pharmacology & translational science · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. 2-Phenethylamines in Medicinal Chemistry: A Review.Molecules (Basel, Switzerland) · 2023
    Review
  17. Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023
    Review
  18. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HTJournal of medicinal chemistry · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christian B M PoulieORCID 0000-0003-2662-9803
Anders A Jensen
Adam L Halberstadt
Jesper L KristensenORCID 0000-0002-5613-1267
University of Health Sciences Antigua · AG

Funding

The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive DrugsR01DA041336 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALBERSTADT, ADAM L. · 2017 to 2020
$1.4M
NIDA NIH HHS R01 DA041336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5-HT2A receptorN-Benzylphenethylaminesnovel psychoactive substancepsychedelics

Identifiers

PMID31657895
PMCPMC9191638
OpenAlexW2981860490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.